Upregulation of Programmed death-1 and its ligand in cardiac injury models: Interaction with GADD153

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Baban, Babak ^a   Liu, Jun Yao ^a   Qin, Xu ^a   Weintraub, Neal L ^b   Mozaffari, Mahmood S ^a  

^a AUGUSTA UNIVERSITY   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; INTERLEUKIN 10; INTERLEUKIN 17; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 RECEPTOR; PROTEIN ANTIBODY; CARDIOTONIC AGENT; CD274 PROTEIN, MOUSE; DDIT3 PROTEIN, MOUSE; NEUTRALIZING ANTIBODY; PDCD1 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; FLOW CYTOMETRY; HEART INJURY; HEART MUSCLE CELL; HEART PROTECTION; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LYMPHOCYTE PROLIFERATION; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; PARACRINE SIGNALING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; REPERFUSION INJURY; T LYMPHOCYTE; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; CARDIAC MUSCLE CELL; CELL COMMUNICATION; CELL PROLIFERATION; COCULTURE; DRUG EFFECTS; FREEZING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; MYOCARDIAL REPERFUSION INJURY; ORGAN CULTURE TECHNIQUE; PATHOLOGY; PRIMARY CELL CULTURE; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIGENS, CD274; APOPTOSIS; CARDIOTONIC AGENTS; CELL COMMUNICATION; CELL PROLIFERATION; COCULTURE TECHNIQUES; FREEZING; GENE EXPRESSION REGULATION; INTERLEUKIN-17; MALE; MICE; MICE, INBRED BALB C; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; ORGAN CULTURE TECHNIQUES; PRIMARY CELL CULTURE; PROGRAMMED CELL DEATH 1 RECEPTOR; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSCRIPTION FACTOR CHOP;

EID: 84930615422     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0124059     Document Type: Article

References (36)

1. Francisco LM, Sage PT, Sharpe AH. The PD-1 pathway in tolerance and autoimmunity. Immunological Reviews. 2010;236:219-242. doi: 10.1111/j.1600-065X.2010.00923.x PMID: 20636820
2. Tarrio ML, Grabie N, Bu D, Sharpe AH, Lichtman AH. PD-1 protects against inflammation and myocyte damage in T Cell-Mediated Myocarditis. J Immunol. 2012;188(10):4876-4884. doi: 10.4049/jimmunol. 1200389 PMID: 22491251
3. Wang L, Han R, Hancock WW. Programmed cell death 1 (PD-1) and its ligand PD-L1 are required for allograft tolerance. Eur J Immunol. 2007;37(10):2983-90. PMID: 17899549
4. Blackburn SD, Crawford A, Shin H, Polley A, Freeman GJ, Wherry EJ. Tissue-specific differences in PD-1 and PD-L1 expression during chronic viral infection: implications for CD8T-cell exhaustion. J Virol. 2010;84:2078-2089. doi: 10.1128/JVI.01579-09 PMID: 19955307
5. Brahmer JR, Drake CG, Wollner I, Powderly D, Picus J, Sharfman WH, et al. Phase I study of singleagent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates. J Clin Oncol. 2010;28:3167-3175. doi: 10.1200/JCO.2009. 26.7609 PMID: 20516446
6. Skuishi K, Apetoh L, Sullivan JM, Blazar BR, Kuchroo VK, Anderson AC. Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity. J Exp Med. 2010;207:2187-2195. doi: 10.1084/jem.20100643 PMID: 20819927
7. Topalian SL, Weiner GJ, Pardoll DM. Cancer immunotherapy comes of age. J Clin Oncol. 2011;29:4828-4836. doi: 10.1200/JCO.2011.38.0899 PMID: 22042955
8. Bodhankar S, Chen Y, Vandenbark AA, Murphy SJ, Offner H. PD-L1 enhances CNS inflammation and infarct volume following experimental stroke in mice in opposition to PD-1. J Neuroinflammation. 2013;10:111 doi: 10.1186/1742-2094-10-111 PMID: 24015822
9. Bu DX, Tarrio M, Maganto-Garcia E, Stavrakis G, Tajima G, Lederer J, et al. Impairment of the programmed cell dealth-1 pathway increases artherosclerotic lesion development and inflammation. ArteriosclerThromb Vasc Biol. 2011;31:1100-1107. doi: 10.1161/ATVBAHA.111.224709 PMID: 21393583
10. Carter LL, Leach MW, Azoitei ML, Cui J, Pelker JW, Jussif J, et al. PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis. J Neuroimmunol. 2007;182:124-134. PMID: 17182110
11. Furukawa Y, Mandelbrot DA, Libby P, Sharpe AH, Mitchell RN. Association of B7-1 co-stimulation with the development of graft arterial disease. Studies using mice lacking B7-1, B7-2, or B7-1/B7-2. Am J Pathol. 2000;157:473-484. PMID: 10934151
12. Kim KS, Denton MD, Chandraker A, Knoflach A, Milord R, Waaga AM, et al. CD28-B7-mediatedTcell costimulation in chronic cardiac allograft rejection: differential role of B7-1 in initiation versus progression of graft arteriosclerosis. Am J Pathol. 2001;158:977-986. PMID: 11238045
13. Ren X, Akiyoshi K, Vandenbark AA, Hurn PD, Offner H. Programmed Death-1 Pathway limits central nervous system inflammation and neurologic deficits in murine experimental stroke. Stroke. 2011;42:2578-2583. doi: 10.1161/STROKEAHA.111.613182 PMID: 21737801
14. Seko Y, Yagita H, Okumura K, Azuma M, Nagai R. Roles of programmed death-1 (Pd-1)/PD-1 ligands pathways in the development of murine acute myocarditis caused by coxsackievirus B3. Cardiovascular Research. 2007;75:158-167. PMID: 17434153
15. Zhang Y, Zhou Y, Lou J, Li J, Bo L, Zhu K, et al. PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction. CritCare. 2010;14:R220. doi: 10.1186/cc9354 PMID: 21118528
16. Baban B, Liu JY, Mozaffari MS. Pressure overload regulates expression of cytokines, yH2AX, and growth arrest- and DNA-damage inducible protein 153 via glycogen synthase kinase-3 (5 in ischemicreperfused hearts. Hypertension. 2013;61(1):95-104. doi: 10.1161/HYPERTENSIONAHA.111.00028 PMID: 23108649
17. Baban B, Liu JY, Mozaffari MS. SGK-1 Regulates Inflammation and Cell Death in the Ischemic-Reperfused Heart: Pressure-Related Effects. Am J Hypertens. 2014;27(6):846-856. doi: 10.1093/ajh/hpt269 PMID: 24429675
18. Baban B, Liu JY, Mozaffari MS. Pressure overload promotes HMGB1 signaling in the ischemic-reperfused heart. Journal of Experimental Clinical Cardiology. 2014;5:286.
19. Mozaffari MS, Liu JY, Abebe W, Baban B. Mechanisms of load dependency of myocardial ischemia reperfusion injury. Am J Cardiovasc Dis. 2013;1;3(4):180-196. PMID: 24224132
20. Miyazaki Y, Kaikita K, Endo M, Horio E, Miura M, Tsujita K, et al. C/EBP homologous protein deficiency attenuates myocardial reperfusion injury by inhibiting myocardial apoptosis and inflammation. ArteriosclerThromb Vasc Biol. 2011;31(5):1124-32. doi: 10.1161/ATVBAHA.111.224519 PMID: 21330607
21. Baban B, Chandler PR, Johnson BA 3rd, Huang L, Li M, Sharpe ML, et al. Physiologic control of IDO competence in splenic dendritic cells. J Immunol. 2011;187(5):2329-35. doi: 10.4049/jimmunol. 1100276 PMID: 21813777
22. Baban B, Chandler PR, Sharma MD, Pihkala J, Koni PA, Munn DH, et al. IDO activates regulatory T cells and blocks their conversion into Th17-likeT cells. J Immunol. 2009;183(4):2475-83. doi: 10. 4049/jimmunol.0900986 PMID: 19635913
23. Becher UM, Ghanem A, Tiyerili V, Fürst DO, Nickenig G, Mueller CF. Inhibition of leukotriene C4 action reduces oxidative stress and apoptosis in cardiomyocytes and impedes remodeling after myocardial injury. J Mol Cell Cardiol. 2011;50(3):570-7. doi: 10.1016/j.yjmcc.2010.11.013 PMID: 21112334
24. van den Bos EJ, Mees BM, de Waard MC, de Crom R, Duncker DJ. A novel model of cryoinjury-induced myocardial infarction in the mouse: a comparison with coronary artery ligation. Am J Physiol HeartCirc Physiol. 2005;289(3):H1291-300. PMID: 15863462
25. Ghebeh H, Mohammed S, Al-Omair A, Qattan A, Lehe C, Al-Qudaihi G, et al. The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors. Neoplasia. 2006;8:190-8. PMID: 16611412
26. Nakanishi J, Wada Y, Matsumoto K, Azuma M, Kikuchi K, Ueda S. Overexpression of B7-H1 (PD-L1) significantly associates with tumor grade and postoperative prognosis in human urothelial cancers. Cancer Immunol Immunother. 2007;56:1173-82. PMID: 17186290
27. Nomi T, Sho M, Akahori T, Hamada K, Kubo A, Kanehiro H, et al. Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer. Clin Cancer Res. 2007;13:2151-7. PMID: 17404099
28. Thompson RH, Kuntz SM, Leibovich BC, Dong H, Lohse CM, Webester WS, et al. Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up. Cancer Res 2006;66:3381-5. PMID: 16585157
29. Thompson RH, Kwon ED. Significance of B7-H1 overexpression in kidney cancer. Clin Genitourin Cancer. 2006;5:206-11. PMID: 17239274
30. Lucas JA, Menke J, Rabacal WA, Schoen FJ, Sharpe AH, Kelley VR. Programmed death ligand 1 regulates a critical checkpoint for autoimmune myocarditis and pneumonitis in MRL mice. J Immunol. 2008;181(4):2513-21. PMID: 18684942
31. Wang W, Carper K, Malone F, Latchman Y, Perkins J, Fu Y, et al. PD-L1/PD-1 signal deficiency promotes allogeneic immune responses and accelerates heart allograft rejection. Transplantation. 2008;86(6):836-44. doi: 10.1097/TP.0b013e3181861932 PMID: 18813109
32. Grabie N, Gotsman I, Da Costa R, Pang H, Stavrakis G, Butte MJ, et al. Endothelial programmed death-1 ligand 1 (PD-L1) regulates CD8+T-cell-mediated injury in the heart. Circulation. 2007;116:2062-2071. PMID: 17938288
33. Ozkaynak E, Wang L, Goodearl A, McDonald K, Qin S, O'Keefe T, et al. Programmed death-1 targeting can promote allograft survival. The Journal of Immunology. 2002;169:6546-6553. PMID: 12444166
34. Chiodi F. Newtherapyto revert dysfunctional antibody responses during HIV-1 infection. J Clin Invest. 2010;120(11):3810-3 doi: 10.1172/JCI44872 PMID: 20972328
35. Rose ML, Coles MI, Griffin RJ, Pomerance A, Yacoub MH. Expression of class I and class II major histocompatibility antigens in normal and transplanted human heart. Transplantation. 1986;41(6):776-780. PMID: 2424159
36. Koga N, Suzuki J, Kosuge H, Haraguchi G, Onai Y, Futamatsu H, et al. Blockage of the interaction between PD-1 and PD-L1 accelerates graft arterial disease in cardiac allografts. ArteriosclerThromb Vasc Biol. 2004;24:2057-2062. PMID: 15374847